Lehrstuhl für Geburtshilfe und Frauenheilkunde

Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. (2024) Massa C, Karn T, Weber KE, Schneeweiss A, Hanusch C, Blohmer JU, Zahm DM, et al. Journal article, Letter Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. (2023) Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev E, et al. Journal article Usability and Perception of a Wearable-Integrated Digital Maternity Record App in Germany: User Study (2023) Nissen M, Perez CA, Jäger K, Bleher H, Flaucher M, Hübner H, Danzberger N, et al. Journal article Fiber alignment in 3D collagen networks as a biophysical marker for cell contractility (2023) Böhringer D, Bauer A, Moravec I, Bischof L, Kah DTE, Mark C, Grundy TJ, et al. Journal article Current landscape of hospital information systems in gynecology and obstetrics in Germany: a survey of the commission Digital Medicine of the German Society for Gynecology and Obstetrics (2023) Pfob A, Griewing S, Seitz K, Hillen C, Becker S, Bayer C, Wagner U, et al. Journal article Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy (2023) Harbeck N, Kates R, Schinköthe T, Schumacher J, Wuerstlein R, Degenhardt T, Lüftner D, et al. Journal article, Review article Prevalence and course of pregnancy symptoms using self-reported pregnancy app symptom tracker data (2023) Nissen M, Barrios Campo N, Flaucher M, Jäger K, Titzmann A, Blunck D, Fasching P, et al. Journal article, Original article Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study (2023) Turner NC, Laird AD, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, et al. Journal article Predicting mammographic density with linear ultrasound transducers (2023) Behrens A, Fasching P, Schwenke E, Gaß P, Häberle L, Heindl F, Heusinger K, et al. Journal article Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant (2023) Neven P, Fasching P, Chia S, Jerusalem G, De Laurentiis M, Im SA, Petrakova K, et al. Journal article